Fierce Pharma

NOVEMBER 19, 2024

Two months after Roche scored FDA approval for its subcutaneous ve | Two months after Roche scored FDA approval for its subcutaneous version of PD-LI inhibitor Tecentriq, Merck has achieved a key milestone in lining up its checkpoint inhibitor Keytruda to follow suit. On Tuesday, the company revealed that its subcutaneous formulation of Keytruda has aced a phase 3 trial, demonstrating non-inferiority to the immunotherapy’s intravenous version.

FDA 292

FDA 292

MedCity News

NOVEMBER 19, 2024

The DEA recently announced the third extension of Covid-19 flexibilities for the virtual prescribing of controlled substances. Telehealth advocates applaud this move but remain hopeful for a more permanent solution in the future. The post Telehealth Advocates Praise DEA’s 3rd Extension of Telemedicine Flexibilities, but Call for Further Action appeared first on MedCity News.

113

113

Fierce Pharma

NOVEMBER 19, 2024

After a labeling mix-up prompted a recall of a popular panic disorder drug this summer, Endo’s U.S. subsidiary is widening the scope of its product pull. | Endo USA is expanding its previous recall of orally disintegrating clonazepam tablets to include more than a dozen additional product lots. The recall is being issued thanks to an “error by a third-party packager” that led to certain cartons displaying the wrong strength and National Drug Code for the product they contain, Endo said.

230

230

PharmaVoice

NOVEMBER 19, 2024

AbbVie’s head of R&D cures has lofty ambitions to end diseases like HIV through a community of researchers that work as one.

Medicine 104

Medicine 104

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

NOVEMBER 19, 2024

Although AstraZeneca, Daiichi Sankyo and England’s drug cost watchdog have spent months trying to hash out a fair price for Enhertu, the trio’s best efforts—and even the intervention of the U.K.’s | Although AstraZeneca, Daiichi Sankyo and England’s drug cost watchdog have spent months trying to hash out a fair price for Enhertu, the trio’s best efforts—and even the intervention of the U.K.’s new health secretary—have failed to yield a solution.

244

244

MedCity News

NOVEMBER 19, 2024

The Silicon Valley startup formerly known as Ciitizen relaunched as Citizen Health. The company seeks to empower patients with access to their complete health history — and it’s starting off by focusing on patients with rare diseases. The post Ex-Invitae Spinoff Relaunches as Citizen Health, Picks Up $14.5M in Seed Funding appeared first on MedCity News.

Patients 109

Patients Biopharma 109

PharmaVoice

NOVEMBER 19, 2024

The company is looking to score an FDA nod for its investigational therapy that targets a molecule linked to Guillain-Barré syndrome and other autoimmune diseases.

FDA 98

FDA 98

Fierce Pharma

NOVEMBER 19, 2024

KnippeRx Transforms Patient Assistance Programs through Technology and Patient-Focused Solutions.

Patients 130

Patients 130

MedCity News

NOVEMBER 19, 2024

What concrete strategies should employers pursue to control rising costs while ensuring the best member experience and clinical outcomes? The post Managing the Specialty Drug Cost Challenge: Is Your Pharmacy Benefits Strategy Ready for 2025? appeared first on MedCity News.

Management 113

Management Pharmaceutical Biopharma Pharma 113

pharmaphorum

NOVEMBER 19, 2024

GSK has reported promising phase 3 results with linerixibat in treating severe itching that plagues patients with primary biliary cholangitis

Patients 91

Patients 91

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

MedCity News

NOVEMBER 19, 2024

Merck said topline Phase 3 results show an injectable version of Keytruda met the main goal of non-inferiority compared to the intravenously infused formulation that is the pharma giant’s top-selling product. Injectable Keytruda could help Merck compete against coming competition from biosimilars. The post Merck Gets a Shot of Confidence From Pivotal Test of SubQ Injectable Keytruda appeared first on MedCity News.

Competition 97

Competition Pharma Biopharma 97

pharmaphorum

NOVEMBER 19, 2024

Researchers from the National Institutes of Health (NIH) are applying artificial intelligence to the recruitment of volunteers into clinical trials, aiming to solve a major obstacle in clinical research.Patient recruitment remains a major challenge for trial sponsors and can lead to delays and increased costs, and traditional methods can be time-consuming and inefficient.

Recruitment 78

Recruitment Patients Leads 78

PharmaTimes

NOVEMBER 19, 2024

The census found that 56% of people visit their GP for a UTI and 27% for thrush

75

75

pharmaphorum

NOVEMBER 19, 2024

Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial

77

77

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

Contrarian Sales Techniques

NOVEMBER 19, 2024

Imagine spending weeks building trust with a doctor or pharmacist, only to find out that counterfeit versions of your product are circulating in the market. It’s a reality for many of us in pharma sales in Malaysia. Counterfeit medicines aren’t just a risk to patients’ health – they’re a blow to the industry’s reputation and our efforts to promote genuine, high-quality treatments.

Medicine 52

Medicine Sales Pharma Doctors 52

pharmaphorum

NOVEMBER 19, 2024

Astellas has suffered another major setback with geographic atrophy (GA) treatment Izervay, this time in the US. The company has received a complete response letter (CRL) from the FDA for a proposed update to the labelling for Izervay (avacincaptad pegol) that sought to include the results of the phase 3 GATHER2 trial and improve the drug's competitive profile against rival Syfovre (pegcetacoplan) from Apellis.

FDA 70

FDA Competition 70

European Pharmaceutical Review

NOVEMBER 19, 2024

Novartis Pharma AG has agreed to a radiotherapeutic radioligand therapy-focused license and collaboration with Ratio Therapeutics. Through this deal, Ratio is eligible to receive milestone payments up to $745 million. The collaboration will utilise Ratio’s expertise in radioligand therapy and its technology platforms for development of a Somatostatin Receptor 2 (SSTR2) radiotherapeutic candidate for cancer.

Food and Drug Administration 52

Food and Drug Administration Manufacturing Food Safety 52

Pharmaceutical Technology

NOVEMBER 19, 2024

SGLT-2I therapies reduce the risk of heart failure and this study clearly demonstrates the benefit of adding them onto GLP-1RA therapy.

59

59

Advertisement

Pharmacy Times

NOVEMBER 19, 2024

Increased global capacity for surveillance could help monitor seasonal influenza to reduce the risk of vaccine mismatch and inform effective interventions.

56

56

PharmaTech

NOVEMBER 19, 2024

Webinar Date/Time: Fri, Dec 13, 2024 11:00 AM EST

52

52

Contrarian Sales Techniques

NOVEMBER 19, 2024

Rural areas in Malaysia offer a unique challenge for pharma sales reps. Here, it’s not just about the product – it’s about the person behind the pitch. Building relationships in these regions goes beyond professional boundaries; it’s about trust, community, and a willingness to go the extra mile – sometimes literally. Why Relationships Are Key in Rural Areas In rural Malaysia, the healthcare ecosystem is often smaller and more close-knit.

Sales 52

Sales Pharma sales reps Pharma Healthcare Provider 52

eMediWrite

NOVEMBER 19, 2024

In the competitive world of pharma marketing, trust isn’t just desirable—it’s essential. Product managers and marketers often ask themselves: How do we communicate value effectively while building credibility? One proven way is by leveraging KOL endorsed case studies and testimonials. Why Case Studies Work Case studies work by offering real-world proof of your product’s effectiveness.

Marketing 52

Marketing Pharma Doctors Competition 52

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Pharmaceutical Commerce

NOVEMBER 19, 2024

The CDMO is investing $3.6 million toward boosting its advanced labeling, automated visual inspection, and fill-finish tech.

52

52

PharmExec

NOVEMBER 19, 2024

Ron Lanton, Partner, Lanton Law, discusses potential challenges that will come as a result of the FDA’s recent move to tighten label restrictions on PD-1 inhibitors for gastric cancers.

52

52

Pharmaceutical Technology

NOVEMBER 19, 2024

The FDA has released a draft of new guidance addressing common FAQs about the development of potential CGT treatments.

FDA 52

FDA 52

Pharmaceutical Commerce

NOVEMBER 19, 2024

Could health system changes that improve patient access to medication have a positive effect on societal welfare?

Medical 52

Medical Patients 52

Advertisement

Distribution

Pharmaceutical Technology

NOVEMBER 19, 2024

The upcoming clinical trial conferences will host talks on supply chain resilience, AI’s growing role and forging industry partnerships.

52

52

pharmaphorum

NOVEMBER 19, 2024

Listen to an insightful podcast interview with Jesse Mendelsohn as he discusses looking to history to prepare for America's uncertain future. Explore valuable insights and perspectives on the topic.

52

52

Pharmaceutical Technology

NOVEMBER 19, 2024

Regenxbio’s plans toward a BLA filing in 2026 after positive data from the Phase I/II AFINITY DUCHENNE trial.

52

52

PharmaTech

NOVEMBER 19, 2024

FDA's approval of eladocagene exuparvovec-tneq (Kebilidi) makes that product the first FDA-approved gene therapy for treating AADC deficiency.

FDA 52

FDA 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales